Transforming growth factor beta 3 in mediating chondrogenic differentiation of mesenchymal stem cells from different sources

doi:10.12307/2022.763

Abstract

Abstract: BACKGROUND: At present, bone marrow mesenchymal stem cells have achieved remarkable results in the treatment of cartilage injury. However, compared with them, nasal mucosal mesenchymal stem cell transplantation has more advantages, such as easier access to patients, safe biopsy without damaging the sense of smell.
OBJECTIVE: To explore the effect of transforming growth factor-β3 on chondrogenic differentiation of nasal mucosal mesenchymal stem cells and bone marrow mesenchymal stem cells.
METHODS: Sprague-Dawley rat nasal mucosal mesenchymal stem cells and bone marrow mesenchymal stem cells were isolated and cultured in vitro. Chondrogenic differentiation medium containing transforming growth factor β3 was used to induce chondrogenesis. In the corresponding control group, chondrogenic differentiation medium without transforming growth factor β3 was utilized for culture. On days 7 and 14, the overall structure was observed and cellular RNA and protein were extracted. RT-PCR and western blot assay were used to detect the expression of chondrocyte-related COL2A1, SOX-9, and Aggrecan.
RESULTS AND CONCLUSION: (1) After 7 days of cartilage induction, both bone marrow mesenchymal stem cells and nasal mucosal mesenchymal stem cells could form a translucent membrane structure, which is difficult to disperse after centrifugation. (2) Compared with the control group, the expression levels of COL2A1 and Aggrecan mRNA were significantly up-regulated after the addition of transforming growth factor β3 into cartilage induced differentiation (P < 0.01). The expression levels of COL2A1 and Aggrecan mRNA in the nasal mucosal mesenchymal stem cell group were higher than those in the bone marrow mesenchymal stem cell group (P < 0.01). After 7 days of intervention, the expression of SOX-9 mRNA of bone marrow mesenchymal stem cells in the experimental group was not significantly different from that in the control group (P > 0.05), but the expression of SOX-9 mRNA of nasal mesenchymal stem cells was significantly higher in the experimental group than that in the control group (P < 0.01). (3) Compared with the control group, the expression levels of COL2A1 and SOX-9 protein were significantly up-regulated after the addition of transforming growth factor β3 into cartilage induced differentiation (P < 0.01). COL2A1 protein expression was higher in the bone marrow mesenchymal stem cell group than that in the nasal mucosal mesenchymal stem cell group on day 14 (P < 0.01). The expression of SOX-9 protein in the experimental group of nasal mucosal mesenchymal stem cells after 7 and 14 days of intervention was significantly higher than that in the experimental group of bone marrow mesenchymal stem cells (P < 0.01). (4) The results show that transforming growth factor β3 has a cartilage stimulating effect on nasal mucosal mesenchymal stem cells and bone marrow mesenchymal stem cells. Nasal mucosal mesenchymal stem cells are also potential candidates for future cartilage repair strategies.

Key words: nasal mucosal mesenchymal stem cells, bone marrow mesenchymal stem cells, transforming growth factor-β3, cartilage injury, chondrogenic differentiation

CLC Number:

Li Ruiyu, Shi Xu, Chen Qi, Zuo Hua, Li Kezhen. Transforming growth factor beta 3 in mediating chondrogenic differentiation of mesenchymal stem cells from different sources[J]. Chinese Journal of Tissue Engineering Research, 2022, 26(30): 4834-4839.

Figures/Tables 4

References

[1] JIANG Y, TUAN RS. Origin and function of cartilage stem/progenitor cells in osteoarthritis. Nat Rev Rheumatol. 2015;11(4):206-212.
[2] NEOGI T. The epidemiology and impact of pain in osteoarthritis. Osteoarthritis Cartilage. 2013;21(9):1145-1153.
[3] DA SILVA MEIRELLES L, CHAGASTELLES PC, NARDI NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci. 2006;119(Pt 11):2204-2213.
[4] KIM SW, LEE IK, YUN KI, et al. Adult stem cells derived from human maxillary sinus membrane and their osteogenic differentiation. Int J Oral Maxillofac Implants. 2009;24(6):991-998.
[5] HWANG SH, PARK SH, CHOI J, et al. Characteristics of mesenchymal stem cells originating from the bilateral inferior turbinate in humans with nasal septal deviation. PLoS One. 2014;9(6):e100219.
[6] HAN C, WANG YJ, WANG YC, et al. Caveolin-1 downregulation promotes the dopaminergic neuron-like differentiation of human adipose-derived mesenchymal stem cells. Neural Regen Res. 2021; 16(4):714-720.
[7] PESTKA JM, BODE G, SALZMANN G, et al. Clinical outcome of autologous chondrocyte implantation for failed microfracture treatment of full-thickness cartilage defects of the knee joint. Am J Sports Med. 2012;40(2):325-331.
[8] CHEN FH, TUAN RS. Mesenchymal stem cells in arthritic diseases. Arthritis Res Ther. 2008;10(5):223.
[9] PITTENGER MF, MACKAY AM, BECK SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143-147.
[10] IM GI, SHIN YW, LEE KB. Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells? Osteoarthritis Cartilage. 2005;13(10):845-853.
[11] LINDSAY SL, MCCANNEY GA, WILLISON AG, et al. Multi-target approaches to CNS repair: olfactory mucosa-derived cells and heparan sulfates. Nat Rev Neurol. 2020;16(4):229-240.
[12] ZHOU F, MA D, OUYANG M, et al. Repair mechanism of mesenchymal stem cells derived from nasal mucosa in orbital fracture. Am J Transl Res. 2018;10(6):1722-1729.
[13] SHAFIEE A, KABIRI M, AHMADBEIGI N, et al. Nasal septum-derived multipotent progenitors: a potent source for stem cell-based regenerative medicine. Stem Cells Dev. 2011;20(12):2077-2091.
[14] GIRARD SD, DEVÉZE A, NIVET E, et al. Isolating nasal olfactory stem cells from rodents or humans. J Vis Exp. 2011;(54):2762.
[15] KARIMI S, BAGHER Z, NAJMODDIN N, et al. Alginate-magnetic short nanofibers 3D composite hydrogel enhances the encapsulated human olfactory mucosa stem cells bioactivity for potential nerve regeneration application. Int J Biol Macromol. 2021;167:796-806.
[16] 吕德民,史文涛,陆浩,等.组织型转谷氨酰胺酶2在鼻黏膜间充质干细胞分化过程中的表达[J].中国组织工程研究,2020,24(19): 2959-2964.
[17] QI C, XIAOFENG X, XIAOGUANG W. Effects of toll-like receptors 3 and 4 in the osteogenesis of stem cells. Stem Cells Int. 2014;2014:917168.
[18] HWANG SH, PARK SH, CHOI J, et al. Age-related characteristics of multipotent human nasal inferior turbinate-derived mesenchymal stem cells. PLoS One. 2013;8(9):e74330.
[19] GE L, JIANG M, DUAN D, et al. Secretome of Olfactory Mucosa Mesenchymal Stem Cell, a Multiple Potential Stem Cell. Stem Cells Int. 2016;2016:1243659.
[20] JOHNSTONE B, HERING TM, CAPLAN AI, et al. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res. 1998;238(1):265-272.
[21] WANG W, RIGUEUR D, LYONS KM. TGFbeta signaling in cartilage development and maintenance. Birth Defects Res C Embryo Today. 2014;102(1):37-51.
[22] DUSFOUR G, MAUMUS M, CAÑADAS P, et al. Mesenchymal stem cells-derived cartilage micropellets: A relevant in vitro model for biomechanical and mechanobiological studies of cartilage growth. Mater Sci Eng C Mater Biol Appl. 2020;112:110808.
[23] SHEN H, LIN H, SUN AX, et al. Acceleration of chondrogenic differentiation of human mesenchymal stem cells by sustained growth factor release in 3D graphene oxide incorporated hydrogels. Acta Biomater. 2020;105:44-55.
[24] ZHANG H, MA X, ZHANG L, et al. The ability to form cartilage of NPMSC and BMSC in SD rats. Int J Clin Exp Med. 2015;8(4):4989-4996.
[25] AKIYAMA H, CHABOISSIER MC, MARTIN JF, et al. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev. 2002;16(21):2813-2828.
[26] JAYASURIYA CT, CHEN Y, LIU W, et al. The influence of tissue microenvironment on stem cell-based cartilage repair. Ann N Y Acad Sci. 2016;1383(1):21-33.
[27] LEFEBVRE V, DVIR-GINZBERG M. SOX9 and the many facets of its regulation in the chondrocyte lineage. Connect Tissue Res. 2017;58(1): 2-14.
[28] AUGELLO A, DE BARI C. The regulation of differentiation in mesenchymal stem cells. Hum Gene Ther. 2010;21(10):1226-1238.
[29] IKEGAMI D, AKIYAMA H, SUZUKI A, et al. Sox9 sustains chondrocyte survival and hypertrophy in part through Pik3ca-Akt pathways. Development. 2011;138(8):1507-1519.
[30] HATA K, TAKAHATA Y, MURAKAMI T, et al. Transcriptional Network Controlling Endochondral Ossification. J Bone Metab. 2017;24(2):75-82.
[31] BUHRMANN C, BUSCH F, SHAYAN P, et al. Sirtuin-1 (SIRT1) is required for promoting chondrogenic differentiation of mesenchymal stem cells. J Biol Chem. 2014 ;289(32):22048-22062.
[32] GONZALEZ-FERNANDEZ T, TIERNEY EG, CUNNIFFE GM, et al. Gene Delivery of TGF-β3 and BMP2 in an MSC-Laden Alginate Hydrogel for Articular Cartilage and Endochondral Bone Tissue Engineering. Tissue Eng Part A. 2016;22(9-10):776-787.
[33] CASANOVA MR, ALVES DA SILVA M, COSTA-PINTO AR, et al. Chondrogenesis-inductive nanofibrous substrate using both biological fluids and mesenchymal stem cells from an autologous source. Mater Sci Eng C Mater Biol Appl. 2019;98:1169-1178.
[34] BHARDWAJ N, DEVI D, MANDAL BB. Tissue-engineered cartilage: the crossroads of biomaterials, cells and stimulating factors. Macromol Biosci. 2015;15(2):153-182.
[35] THORP H, KIM K, KONDO M, et al. Fabrication of hyaline-like cartilage constructs using mesenchymal stem cell sheets. Sci Rep. 2020;10(1): 20869.
[36] PELTTARI K, PIPPENGER B, MUMME M, et al. Adult human neural crest-derived cells for articular cartilage repair. Sci Transl Med. 2014; 6(251):251ra119.
[37] MUMME M, BARBERO A, MIOT S, et al. Nasal chondrocyte-based engineered autologous cartilage tissue for repair of articular cartilage defects: an observational first-in-human trial. Lancet. 2016; 388(10055):1985-1994.